Experts emphasize that the occurrence of blood clots as a side effect after receiving the AstraZeneca vaccine is extremely rare and typically happens within 42 days post-vaccination. Despite concerns raised after AstraZeneca acknowledged the potential risk of blood clots associated with their Covid-19 vaccine, health authorities stress that this adverse event is infrequent and treatable.
In Ho Chi Minh City, where over 9 million doses of the AstraZeneca vaccine have been administered since March 2021, no cases of blood clots following vaccination have been reported. Director of the Department of Health, Tang Chi Thuong, reassured the public that the benefits of the vaccine in preventing severe illness far outweigh the minimal risk of blood clotting. He pointed out that the occurrence of blood clots can also be triggered by other factors, including Covid-19 infection itself.
Health experts urge people not to panic and to continue getting vaccinated. It is advised to monitor for any unusual symptoms post-vaccination and seek medical attention if necessary. The World Health Organization emphasizes the importance of vigilance, early detection, and prompt treatment of rare events, such as thrombocytopenia and blood clots, in individuals following Covid-19 vaccination.
Furthermore, medical professionals stress that blood clots can arise in various clinical scenarios, not just after vaccination. Covid-19 itself can lead to severe coagulation issues, underscoring the critical need for vaccination. The European Medicines Agency has endorsed the continued use of the AstraZeneca vaccine, providing guidance on the identification and management of potential complications.
In conclusion, while acknowledging
